All lobbying filings

EMERGENT STRATEGIES

Lobbying for ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION · trade association representing the advanced medical technology industry

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $45,000.00 income · posted Apr 21, 2025

Official filing document

Bills named in this filing 2

S 5349
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
HR 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Lobbying activity 5

Trade (domestic/foreign)

Issues related to CHIPS implementation

Medical/Disease Research/Clinical Labs

Health tax issues and trade Issues related to Small Business Innovation Research Program PAHPA Reauthorization

Taxation/Internal Revenue Code

Issues relating to health tax issues and trade

Computer Industry

Issues related to health data privacy

Medicare/Medicaid

Issues on legislation pertaining to H.R.1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023 Issues on legislation pertaining to S.5349 Ensuring Patient Access to Critical Breakthrough Products Act of 2024 Issues related to transitional coverage of emerging technologies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.